Skip to main content
. 2022 Dec 20;15(1):3. doi: 10.3390/pharmaceutics15010003

Table 2.

Overall aerosol properties of M33_PEG 2000-Rhod and M33_PEG 5000-Rhod delivered through Aeroneb® Go and PARI TurboBOY nebulizers: Experimental mass median aerodynamic diameter (MMADexp) and geometric standard deviation (GSD) were calculated by plotting cumulative mass of particles retained in each collection cup versus the cut-off diameter of the corresponding stage. The fine particle fraction (FPF) was calculated as the percentage of NPs deposited in stages 3–7 (MMADexp < 5.39 μm) compared to the amount initially loaded in the nebulizer chamber. The respirable fraction (RF) is the total amount recovered from the NGI. Data are reported as mean ± SD (n = 3).

M33_PEG 2000RhodNPs M33_PEG 5000RhodNPs
Aeroneb PARI TurboBOY Aeroneb PARI TurboBOY
FPF 37.1 ± 16.3 39.4 ± 9.5 40.5 ± 0.1 43.0 ± 5.7
RF 71.1 ± 1.6 71.2 ± 7.4 50.0 ± 7.8 67.5 ± 2.2
MMADexp 2.68 ± 1.03 2.66 ± 1.02 3.85 ± 0.70 2.53 ± 0.71
GSD 2.91 ± 0.98 2.66 ± 0.58 2.62 ± 0.02 2.86 ± 0.47

FPF, fine particle fraction; RF, respirable fraction; MMADexp, experimental mass median aerodynamic diameter; GSD, geometric standard deviation.